Inhibition of HSC activation |
Apigenin |
In vitro HSCs |
Upregulating C1QTNF2 expression |
[107] |
EGCG |
In vitro HSCs & thioacetamide-treated animal |
Upregulating miR-221 to accelerate osteopontin degradation |
[108] |
Quercetin |
Rats with CCl4-induced fibrosis |
Activation of MMPs and regulating profibrogenic/antifibrogenic molecules balance |
[109] |
Icaritin |
In vitro HSC-T6 and LX-2 HSC lines & rats with CCl4 or CBDL-induced fibrosis |
Dependent on mitochondrial-activated apoptosis |
[110] |
Curcumin |
In vitro HSCs & animal model |
Suppressing membrane translocation and gene expression of GLUT2; inhibiting PPARγ via regulation of DLK1 protein partly mediated by interruption of Shh signaling pathway |
[111, 112] |
Resveratrol |
Rats with N′-nitrosodimethylamine-induced liver fibrosis |
Relieving oxidative damage |
[113] |
|
Induce HSC apoptosis |
Hyperoside |
In vitro human LX-2 HSCs |
Inhibiting the DNA-binding activity of NF-κB and altered genes related to apoptosis |
[125] |
Morin |
In vitro HSCs |
Suppressing canonical NF-κB signaling |
|
Gallic acid |
In vitro HSCs |
Regulating TNF-α signaling pathway |
[114] |
Quercetin |
In vitro HSCs |
Dependent on activation of ER stress |
[115] |
|
Inhibit proliferation and profibrogenesis-related genes in HSCs |
Chrysin |
Mice with CCl4-induced fibrosis |
Suppressing TGF-β1/Smad pathway |
[116] |
Tricin |
In vitro human HSC line LI90 |
Blocking tyrosine phosphorylation of PDGF receptor |
[117] |
Chlorogenic acid |
In vitro HSCs & CCl4-treated rats |
Improving antioxidant capacity via activation of Nrf2 pathway and suppressing profibrotic action via inhibition of NOX/ROS/MAPK pathway |
[118] |
Luteolin |
In vitro rat HSCs and HSC-T6 cells & rat models induced by CCl4, DMN, and BDL |
Increasing caspase 3 activity and p53 expression; inducing G1 arrest with the decreased expression of bcl-2, cyclin E, and p-Cdk-2; suppressing PDGF and TGF1-simulated phosphorylation of AKT and Smad pathway |
[126] |
Resveratrol |
In vitro human LX-2 HSCs & mice with CCl4-induced fibrosis |
Suppressing the activation of NF-κB and Akt |
[119] |
EGCG |
In vitro HSC LX-2 & BDL rats |
Inhibiting PI3K/Akt/Smad pathway |
[120] |
Wogonoside |
In vitro HSC T6 cells & mice with CCl4-induced fibrosis |
Inhibiting PI3K/Akt/mTOR/p70S6K |
[121] |
|
Attenuate liver injury and antifibrosis |
Morin |
Rats with CCl4-induced fibrosis |
Reducing oxidative stress, inflammatory responses, and fibrogenic markers |
[122] |
Chlorogenic acid |
Rats with CCl4-induced fibrosis |
Inhibition of TLR4/MyD88/NF-κB signaling pathway |
[123] |
Curcumin |
Mice with type 2 diabetes mellitus |
Suppressing the AGEs-mediated induction of RAGE gene expression by increasing PPARγ and stimulating GSH |
[124] |
Total flavonoids of Astmgali Radix
|
Rats with fibrosis |
Regulating PPAR signal pathway and the interaction with FXR |
[127] |